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University of Leeds, Leeds, United KingdomABSTRACT Themechanical failure of mature amyloid fibers produces fragments that act as seeds for the growth of new fibrils.
Fragmentation may also be correlated with cytotoxicity. We have used steered atomistic molecular dynamics simulations to
study the mechanical failure of fibrils formed by the amyloidogenic fragment of human amylin hIAPP20-29 subjected to
force applied in a variety of directions. By introducing systematic variations to this peptide sequence in silico, we have also
investigated the role of the amino-acid sequence in determining the mechanical stability of amyloid fibrils. Our calculations
show that the force required to induce mechanical failure depends on the direction of the applied stress and upon the degree
of structural order present in the b-sheet assemblies, which in turn depends on the peptide sequence. The results have
implications for the importance of sequence-dependent mechanical properties on seeding the growth of new fibrils and the
role of breakage events in cytotoxicity.INTRODUCTIONAmyloid fibrils are formed when peptides or misfolded
proteins self-assemble into filamentous aggregates. They
are associated with a number of neurodegenerative and
pathological human diseases such as Alzheimer’s, Parkin-
son’s, and type II diabetes (1). It is still not clear, however,
if the fibrils are the cause or merely symptomatic by-
products of the disease (2). Although some studies have
shown that the oligomeric structures arising during the early
stages of fibril formation are toxic (2–4), other studies
indicate that the mature fibrils are also toxic agents (5–7).
Moreover, the brittleness of amyloid fibrils also influences
aggregation and toxicity. In yeast prions, the fragmentation
of mature fibrils has been shown to increase fibril load
through seeding by increasing the number of ends from
which new fibrils may grow (8,9). The fragility of these
fibrils also dictates the strength and penetrance of the strain
phenotype in different yeast species (8).
Experimental work using a range of fibril species,
including b2-microglobulin and a-synuclein, has high-
lighted a connection between the fragmentation of mature
fibrils and an increase in their toxic properties (10,11). In
these studies, reducing the fibril length through mechanical
agitation made the fibrils more disruptive to liposome
membranes and more cytotoxic to the cell lines studied.
Another study using two conformationally distinct poly-Submitted September 9, 2011, and accepted for publication December 9,
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fragments were indeed more toxic for one state but that the
fragments of the other state were substantially less toxic
than the intact fibrils (5). A firm understanding of the struc-
tural factors that influence the mechanical brittleness of
fibrils, the choreography of breakage events, and the molec-
ular details of the fragments remaining after mechanical
failure could aid in the interpretation of seeding and toxicity
experiments and ultimately provide a basis for the design of
therapeutic agents to combat amyloid disease.
Despite the biomedical importance of the mechanical
properties of amyloid fibrils, few biophysical techniques
are available that are able to characterize their response
to force experimentally at the molecular level. This is due
in part to practical limitations on how the fibrils can be
prepared and tethered while the deformation is applied.
Atomic force microscopy (AFM) has been used to mechan-
ically probe an adhesive secreted by a marine invertebrate
(Entobdella soleae) (12,13) that contains mechanically
functional amyloid. The AFM technique has also been
used to measure the elastic modulus of a number of amyloid
and amyloidlike fibril species through force spectroscopy
and nanoindentation (14–18) experiments that measure the
local response of a selected region rather than that of the
fibril as a whole.
Analysis of AFM topographic data taken from images of
a number of fibril species, to obtain their bending rigidity,
reveals that fibrils have a high elastic modulus whose molec-
ular basis stems from backbone intermolecular hydrogen
bonding (19). Synchrotron x-ray diffraction at high pres-
sures has been used to study fibrils under mechanical com-
pression (20) and reproduces elastic moduli comparable
to AFM experiments. Computer simulations, in which the
geometry of the system being studied and the manner
in which force is applied can be precisely controlled,doi: 10.1016/j.bpj.2011.12.047
588 Ndlovu et al.are particularly valuable in complementing experimental
studies. Steered molecular dynamics (SMD) simulations
have been used to probe the force-induced unbinding of
a single peptide from Ab fibrils (21) and demonstrated
an anisotropic response relative to the pulling direction.
Computer simulations have also been used to measure the
Young’s modulus of Ab fibrils (22). These simulations
probed the fibrils’ response to compressive loading and their
failure under tensile loading conditions (22–24).
In this work, atomistic SMD has been used to apply suffi-
cient mechanical stress to induce mechanical failure, during
which fibrils formed by the wild-type and a series of variants
of the amyloidogenic region of human amylin hIAPP20-29
are forced to fragment into two or more aggregates that
are then separated by intervening solvent molecules. Four
deformation protocols that apply force in a defined direction
were chosen so as to interrogate either the stabilizing hydro-
phobic core interactions between a pair of b-sheets or the
hydrogen-bond network within each b-sheet. A schematic
representation of the four schemes (peel, stretch, slide,
and shear) is provided in Fig. 1. Peel involves pulling the
pair of stacked b-sheets apart, whereas stretch elongates
the fibril along its length until it reaches its tensile limit.
Shear applies forces perpendicular to the length of the fibril
by pulling atoms along the axis of the peptide strands.
Finally, the slide deformation drags one entire b-sheet
across another with the pulling direction parallel to the fibril
long axis.FIGURE 1 (Color available online only.) Schematic representation of
the deformations applied to fibril models. Each deformation is defined by
pulled/fixed atom choice (either A or B) and then a pulling direction
(n1, n2, or n3). (Green) Peptides whose backbone Ca atoms are pulled.
(Red) Peptides with Ca atoms held fixed. All other atoms in these peptides
are free to move. Peel deformation: option A and n1. Stretch deformation:
option B and n2. Slide deformation: option A and n2. Shear deformation:
option B and n3.
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fibrils subjected to force applied in a variety of directions,
we have also investigated the role played by the amino-
acid sequence in the mechanical stability of amyloid fibrils.
Model fibrils were built from the amyloidogenic fragment of
human amylin SNNFGAILSS peptide sequence based on
structural information on the parallel b-sheet polymorph
available from solid-state (ss) NMR (25). This sequence
and its derivatives have been widely used in both ex-
perimental (26–31) and computational studies (32–35) of
amyloid-related phenomena. We then designed a series of
peptide sequences in which an increasing proportion of resi-
dues are substituted with those present in the nonamyloido-
genic rat amylin counterpart (see Table 1). The rat sequence
acts as a control for the SMD simulations because it is not
able to form stable amyloid fibrils in vitro (26). The variants
were chosen so that none of the amino-acid substitutions
removes or adds a residue that is a potential donor or
acceptor of side-chain hydrogen bonds. The first three and
last two residues of hIAPP were therefore not changed
(except in rat-IAPP), as these residues (Ser and Asn) can
potentially participate in side-chain hydrogen bonding.
Model fibrils for this series of new sequences were con-
structed in silico by substituting the appropriate residues
in the wild-type ssNMR structure.MATERIALS AND METHODS
A more detailed description of the methods used is provided as the
Supporting Material.Construction of the fibril models
The initial fibril model was built from coordinate files derived from solid
state NMR data for the parallel polymorph of SNNFGAILSS fibril (25)
using the Nucleic Acid Builder software package (36). The model fibril
consisted of a pair of b-sheets, each containing eight peptides (an 8 2 fibril
model). The peptide sequence of the 8  2 model was altered (see the
Supporting Material) to produce six distinct fibril variants, each of which
contain one or more amino acids from the nonamyloidogenic rIAPP
sequence. The relevant substitution was applied to all 16 peptides in the
pair of b-sheets. The naming convention adopted for these substitutions
arise from numbering the amino-acid residues of the SNNFGAILSS
sequence from 1 to 10, and are provided in Table 1. For example, the
F4L variant relates to a substitution of Phe in the fourth position with a
Leu residue.TABLE 1 Models built from substitutions of amino acids from
the original hIAPP2029 sequence
Model Peptide sequence
Wild-type (hIAPP) NH2- SNNFGAILSS-COOH
F4L NH2- SNNLGAILSS-COOH
A6P NH2- SNNFGPILSS-COOH
I7V NH2- SNNFGAVLSS-COOH
F4L-A6P NH2- SNNLGPILSS-COOH
F4L-A6P-I7V NH2- SNNLGPVLSS-COOH
Rat-IAPP NH2- SNNLGPVLPP-COOH
Specific changes are underlined.
MD of Amyloid Fibril Fragmentation 589Molecular dynamics simulations
MD simulations were run in both the AMBER9 (37) and NAMD2.7b1 (38)
software packages, with the all-atom AMBER99SB (39) and the
CHARMM22/CMAP (40) force fields, respectively. The 8  2 ssNMR
model and the associated fibril variants were explicitly solvated in a periodic
water box of TIP3P (41) molecules. The fibrillar assemblies were subjected
to careful equilibration before the unrestrained production run of 22-ns MD
for each fibril model. All MD was run at constant temperature (300 K) and
pressure (1 atm). Convergence was monitored using the root mean-square
deviation and was sufficient for all models within the final 6 ns of 22-ns
MD (see Fig. S1 in the Supporting Material). To check that these conforma-
tions were force-field-independent, the simulations were rerun in NAMD
using the CHARMM22/CMAP force field. No significant structural
changes were observed after 10 ns of these validation simulations.Steered molecular dynamics
Conformations of the fibrils from the end of the unrestrained MD simula-
tions served as initial structures for steered molecular dynamics (SMD)
simulations to characterize mechanical stability. SMD was performed using
the NAMD2.7b1 package (38) and the CHARMM22/CMAP force field
(40). The deformations (peel, stretch, shear, and slide) consisted of forcing
a defined set of atoms to move (using a spring constant of 500 pN/A˚) at
a constant pulling velocity (0.01 A˚/ps) while another group of atoms was
fixed (Fig. 1). All other atoms are free to move during the simulations.
SMD was performed for 4 ns, except for the peel simulations that were
only 2 ns, due to the smaller displacements required for this deformation
mode. Each SMD simulation was repeated four times, with randomized
starting velocities to ensure the trajectories sampled different areas of phase
space. Additional simulations to check the dependence of mechanical re-
sponse on the choice of force field were carried out using the AMBER99SB
force field. The trends recorded in the simulations using the CHARMM22/
CMAP and AMBER99SB force fields were similar (see Fig. S2 a). A series
of peel simulations was also performed at different pulling velocities
(0.5, 0.1, 0.05, 0.01, and 0.001 A˚/ps), which demonstrated that the trends
in peak force with sequence are not unique to the pulling velocity chosen
(see Fig. S2 b) during this deformation.Analysis methods and calculations
Analysis of the unrestrained MD simulations was performed on snapshots
sampled every 1 ps from the final 6 ns of the MD trajectory. Secondary
structure content was monitored using the DSSP method (42) via the
PTRAJ module in the AMBER 9 package (37). The HBONDS utility avail-
able in VMD (43) was used to analyze the occupancies of the backbone and
side-chain interstrand hydrogen bonds. The MM-PBSA methodology as
implemented in AMBER11 (37) was used to calculate enthalpies of the
fibril models stripped of solvent molecules. Noise reduction in force-time
profiles was achieved with a moving median filter (see Fig. S3).FIGURE 2 (Color available online only.) Final configurations of the
fibrils at the end of the (22 ns) MD simulations performed in the absence
of force. (a) Wild-type model with sequence SNNFGAILSS, (b) variant
with F4 substituted with leucine (marked in yellow), (c) variant with A6
substituted with proline (marked in red), (d) variant with I7 substituted
with valine (marked in green), (e) double substitution F4L/A6P, (f) triple
substitution A6P/F4L/A6P, and (g) the nonamyloidogenic rat amylin
fragment SNNLGPVLPP.RESULTS
Effect of sequence substitution on fibril
conformation
To examine the effect of the sequence substitutions on fibril
structure and energetic stability, models of fibers containing
two b-sheets, each comprised of eight b-strands in a parallel
organization, were constructed in silico. Unrestrained MD
simulation was run for 22 ns on the model fibrils con-
structed from the wild-type (based on ssNMR structures
of SNNFGAILSS (25)) and each of the related sequencevariants, and the final 6 ns subjected to analysis. The result-
ing structures (Fig. 2) showed effects that ranged from
subtle changes to drastic reductions in the degree of order
in the aggregates relative to the wild-type model. To quan-
tify the degree of order within the fibrils, the mean fraction
of secondary structure elements present during the course of
the dynamics was computed and is shown in Fig. 3 a. The
mean occupancies of interstrand backbone hydrogen bonds
and side-chain hydrogen bonds are shown in Fig. 3 b. The
calculated energetic stabilities of the variant models relative
to the wild-type fibrils are shown in Fig. 3 c. The individual
energy terms contributing to the enthalpy are listed in
Table S1 in the Supporting Material for each fibril model.
Of the single point changes, the substitution of phenylal-
anine for leucine at position 4 (F4L) results in a model fibril
that is most similar to that formed by the wild-type sequence
after MD, because the proportion of b-strands and number
of backbone and side-chain hydrogen bonds is identical
(within error) in the two fibril models (Fig. 3, a and b).
This observation is consistent with experimental data from
electron microscopy (EM) and transmission electron
microscopy images, which show that fibril aggregatesBiophysical Journal 102(3) 587–596
FIGURE 3 (Color available online only.) (a) Mean fraction of secondary
structure elements present in each fibril model from 1-ps snapshots of the
final 6 ns of MD simulation. (Blue) b-strand content. (Green) Random coils.
(b) Mean number of interstrand backbone (yellow) and side-chain (red)
hydrogen bonds recorded in the final 6 ns of MD. (c) The configurational
enthalpy plotted relative to the wild-type fibril model.
590 Ndlovu et al.form readily from the F4L variant, giving rise to fibrils that
are morphologically identical to those formed from the
wild-type peptide (26,30). EM images obtained by Wester-
mark et al. (26) of fibrils formed from the isoleucine-to-
valine (I7V) variant show that the fibril bundles also have
a similar morphology to those formed from the wild-type
peptide. During the MD, the substitution of isoleucine for
valine (I7V) results in a shift of one b-sheet relative to the
other, with the N-terminal regions on the opposing sheetsBiophysical Journal 102(3) 587–596becoming more solvent-exposed than in the wild-type
fibrils. Nevertheless, the aggregates remain ordered, with
only a 15% and 20% decrease in hydrogen bonding and
b-sheet content, respectively (Fig. 3, a and b), and no
measurable change in the number of side-chain hydrogen
bonds.
Both the F4L and I7V fibrils are more energetically stable
than the wild-type fibril model (Fig. 3 c). In contrast, the
introduction of a proline residue in place of alanine (A6P)
disrupts the fibril structure and results in an increase of
random coiled regions at the expense of the b-strand motif
(Fig. 3 a), reduced side-chain hydrogen bonding (Fig. 3 b),
a reduced energetic stability relative to the wild-type
(Fig. 3 c), and aggregates that are visibly disordered
(Fig. 2). TheEM images fromWestermark et al. (26) of fibrils
formed by the A6P variant show that fibrils formed from
this sequence are morphologically distinct from those
formed from the wild-type peptide. The double (F4L-A6P)
and the triple (F4L-A6P-I7V) substitutions give rise to fibrils
that share similar secondary structure characteristics to
each other; A6P-I7V possessed more (72 5 4 compared
with 66 5 4) interstrand backbone hydrogen bonds at the
end of MD, but there were no detectable differences in
side-chain hydrogen-bonding interactions between the two
variants. The fibril model mimicking the nonamyloidogenic
rat sequence, SNNLGPVLPP, which contains three proline
residues, showed a dramatic transition from its initial
ordered configuration into an amorphous globularlike aggre-
gate of random coils (Figs. 2 g and 3 a). There is also a sig-
nificant reduction in the energetic stability relative to its
wild-type counterpart (Fig. 3 c) by the end of the MD simu-
lation. This is consistent with experimental studies that show
that this sequence is unable to form stable amyloid fibrils
(26). In the SMD simulations described below, this amor-
phous aggregate serves as the reference state for quantifying
the mechanical resistance of ordered fibril models.The mechanical strength of fibrils depends on the
type of deformation applied and on sequence
To characterize the different mechanical resistances of
model fibrils formed from the wild-type fragment of hIAPP
and its six variants, structures taken from the end of the
initial MD simulations were each subjected to four equiva-
lent SMD simulations in each of the four deformation direc-
tions shown in Fig. 1 (112 SMD simulations in total).
Fig. 4, a–d, shows a selection of representative configura-
tions of the fibrils sampled from the peel, stretch, slide,
and shear SMD simulations. The relevant force-time profile
is plotted alongside for one of the four repeat simulations.
Fig. S4 in the Supporting Material shows the force-time
profiles measured for the wild-type fibril models in the
four pulling directions. Although each repeat SMD simula-
tion follows a slightly different path through conforma-
tional space, similar features are observed in all equivalent
FIGURE 4 (Color available online only.) Representative snapshots of the fibrils evolving in time as the different deformation protocols are applied. (Right
side of each snapshot sequence) Relevant force-time profile is plotted. (Solid red line) Filtered signal from which the peak force is measured. (a) Peel,
F4L-A6P trajectory. (b) Stretch, I7V trajectory. (c) Slide, F4L-A6P trajectory. (d) Shear, wild-type fibril trajectory.
MD of Amyloid Fibril Fragmentation 591force-time profiles. The force profiles for the six variant
fibrils are shown in Fig. S5, Fig. S6, Fig. S7, and Fig. S8.
The magnitude of the average peak force calculated over
the four repeat simulations was used as a measure of the
mechanical resistance of the fibril to deformation along
a particular direction. The peak force is defined as the
maximum force exerted during a given SMD simulationafter the data have been filtered to reduce thermal noise
(see the Supporting Material). For the rat amylin sequence
(rIAPP20-29), which collapses during the equilibration
phase into a disordered aggregate, some of the SMD proto-
cols (such as sliding sheets past each other) become ambig-
uous and difficult to implement. In these cases, all four
deformation simulations were carried out for the rIAPPBiophysical Journal 102(3) 587–596
592 Ndlovu et al.variant using atom selections consistent with those used for
the other models. Fig. 5 a shows the mean peak forces
measured for wild-type fibrils and all six variants. The
peak force observed is due to random thermal fluctuations
alone (see Fig. S3) is shown as a dashed line for reference).
Fig. 5 b shows the mean peak force normalized by the
number of interaction interfaces interrogated during the
deformations. Fig. 5 c shows the directional stiffnessFIGURE 5 (a) (Color available online only.) Summary of the mean peak
forces recorded for the seven fibril models during each type of fragmenta-
tion simulation (extracted from the data after filtering). (Dashed line)
Maximum noise signal level. (Error bars) Standard error of the mean calcu-
lated from the four repeat simulations. (b) Normalized peak force values in
terms of number of interaction interfaces disrupted during the deformation
(two for stretch and shear, eight for peel and slide). (c) Directional stiffness
constants extracted from the gradient of the force versus displacement
graphs in the linear region (before exertion of the peak force).
Biophysical Journal 102(3) 587–596constants for each of the seven model fibrils measured for
the four different SMD pulling protocols. These directional
stiffness constants were obtained from the gradient of the
force versus displacement plots (see Fig. S9) measured in
the linear response regime and averaged over the repeat
simulations.
The magnitudes of the forces measured by SMD are
known to be dependent on the pulling velocity used to
enforce the conformational change (44,45), as shown in
Fig. S2 b, and as was observed from simulations detaching
single peptides from Ab fibrils (21). However, because the
magnitudes and durations of the forces experienced by
individual fibrils during fragmentation by stirring (which
has been shown to affect the cytotoxicity of fibrils (5,10))
are unknown, it is the changes in the mechanical properties
of the fibril models with sequence and the mode of
deformation that are most relevant, as these will apply
more generally than the absolute magnitudes of the forces.
Fig. 5, a and b, shows that the peak forces measured for
the disordered rIAPP aggregate are the lowest for all defor-
mations. The overall mechanical strength of each aggregate
is governed by the weakest force required to induce struc-
tural failure in any direction. Using this criterion, the
wild-type fibrils are the strongest, whereas the A6P and
the rIAPP variants offer the least resistance to an applied
force. Nevertheless, the disordered aggregates consistently
have mechanical resistance above the levels of thermal
noise due to the presence of van der Waals (see Table S1)
and hydrogen-bonding interactions (Fig. 3 b) between the
peptide strands.
Fig. 5, a and b, shows that the peak forces required to
fragment the model fibrils depend on both the peptide
sequence and the directionality of the deformation applied
during the SMD. Fig. 5 c shows that the stiffness constants
measured in the linear response regime before the applica-
tion of the peak force are also sequence-dependent and
anisotropic. Single molecule experiments and SMD simula-
tions to probe the fracture forces necessary to disrupt the
structure of folded proteins have previously shown that the
mechanical resistance is dependent on the pulling geometry
(46–48); here we show that this is also the case in SMD
simulations of peptide assemblies. This is consistent with
the observation that there is no direct correlation between
the enthalpic stability of a model fibril and its mechanical
resistance in silico, as can be seen from comparing
Fig. 3 c and Fig. 5, a–c, because fibril fragmentation is a
nonequilibrium process during the SMD calculations.Interatomic interactions in the fibril determine
the response to mechanical stress
Fig. 5 b shows that all ordered fibrillar aggregates are most
resistant (per interaction interface) to the stretch deforma-
tion, which directly interrogates the strength of the inter-
b-sheet hydrogen bonds along the long axis of the fibril
FIGURE 6 (Color available online only.) Orientation and alignment of
Phe residues on opposing b-sheets. (a) Side and (b) top view for wild-
type. Top view for (c) F4L (replacement Leu shown in black and gray),
(d) I7V, and (e) A6P variants.
MD of Amyloid Fibril Fragmentation 593that are primarily responsible for the general occurrence of
amyloid. Comparing Fig. 5 b with Fig. 3 a shows that the
mechanical resistance of fibrils to stretch is higher when
there is more interstrand hydrogen bonding and the aggre-
gate has greater b-sheet content. As the sequences of the
variants were chosen to minimize differences in side-chain
hydrogen-bonding interactions, the number of side-chain
hydrogen bonds is similar for all variants (with the excep-
tion of rat-IAPP and A6P, Fig. 3 b). Consequently, the
side-chain interactions play a relatively minor role in deter-
mining the sequence dependence of the mechanical resis-
tance to stretch for this choice of variants.
Fibrils are consistently less resistant to the shear deforma-
tion than to stretch (Fig. 5, a–c), as shear places stress on the
b-sheet hydrogen-bonding network perpendicular to the
long axis of the fibril rather than along its length. This
implies that the hydrogen-bonding network provides a
cooperative resistance to forces applied along the fibril.
The peel and slide deformations primarily address the
hydrophobic core intersheet interactions within the fibrils.
The peel deformation—in which the b-sheets are forced
apart, thus exposing the hydrophobic core—was responsible
for the two largest peak forces (2804.33 5 237.15 pN for
the wild-type and 2253.885 201.26 pN for I7V) measured
by the SMD simulations (Fig. 5 a). The relative importance
of peel and slide was particularly sequence-dependent, as
might be expected, because it depends on the molecular
details of the packing within the hydrophobic core.
Fig. S10 and Fig. S11 show a more detailed analysis of
the energetic changes that produce the different force pro-
files in the peel and slide SMD.Role of Phe-Phe interactions within
the hydrophobic core
Although the F4L variant has similar secondary structure
content and backbone hydrogen bonds to the wild-type
fibrils (Fig. 3, a and b), it records a significantly smaller
mean peak force and a reduced mechanical stiffness con-
stant (Fig. 5, a and c) in the peel simulations. The reasons
for the differences in mechanical robustness of the wild-
type sequence relative to the other models during the
SMD simulations can be traced to intersheet Phe-Phe inter-
actions. In the wild-type sequence, the Phe residues from
opposite sheets orient themselves in such a way that they
are interdigitated (Fig. 6, a and b), which confers the addi-
tional mechanical strength to the model fibrils observed in
the peel calculations. In contrast, the leucine substitutions
in the F4L variant are significantly further apart (17.75 5
0.34 A˚ between the center of masses of Leu pairs on oppo-
site b-sheets relative to 9.70 5 0.14 A˚ for corresponding
Phe pairs in the wild-type), as shown in Fig. 6 c. Similarly,
in the I7V variant, which undergoes a shift of one b-sheet
relative to the other, the Phe pairs on opposite sheets
are much further apart (19.56 5 0.63 A˚) before SMD(Fig. 6 d). For A6P, which has reduced b-sheet content rela-
tive to the wild-type, structural disorder in the model fibril
gives rise to a random orientation of the Phe residues
(Fig. 6 e). We attribute the reduced mechanical resistance
to peel observed for these variants to the absence of close-
packed intersheet Phe residues in the model fibrils.Fibrils have weak points that reduce their
mechanical resistance
All ordered fibrillar aggregates demonstrated the greatest
resistance per interface to the stretch deformation, which
directly interrogates the strength of the hydrogen-bonding
network along the long axis of the fibril. The wild-type, I7V,
F4L-A6P, and F4L-A6P-I7V fibrils display mean peak forces
under stretch of ~1000 pN. However, the mean peak force for
the F4L, A6P, and rIAPP variants is significantly lower
(719.20 5 46.39pN, 682.95 5 53.65pN, and 377.79 5
59.96pN, respectively) with correspondingly lower stiffness
constants (Fig. 5 c). Fig. 3 a shows that the disruptive effect
of the proline substitution in the A6P and rIAPP variants
results in aggregates containing a higher proportion of
disordered strands (63% and 78%, respectively, compared
to only 34% for the wild-type), indicating that there are
numerous positions where the chain of inter-b-sheet
hydrogen-bonding interactions are interrupted (see Fig. 3 b).
The reduced mechanical resistance of aggregates con-
structed from these sequences can be explained by theBiophysical Journal 102(3) 587–596
594 Ndlovu et al.increased number of defects present in these structures.
These defects act as fracture points that are the first to
undergo mechanical failure under stress. The importance
of these defects is emphasized by the anomalously low
mean stretch force recorded for the F4L variant. Although
aggregates of this sequence possess equivalent secondary
structure content compared to the other structurally ordered
fibrils, some of the SMD simulations performed start from
an aggregate containing a defect in which a single peptide
strand in a disordered conformation interrupts an otherwise
ordered b-sheet (see Fig. S12). This defect acts as a weak
spot in the fibril, and despite the robustness of the rest of
the structure it nevertheless undergoes mechanical failure
at comparatively low forces.
To test the hypothesis that the defects can be the cause of
structural failure in fibrils, longer (16  2) models of the
wild-type sequence were constructed containing a defect
(in the form of a disordered b-strand five strands from one
end of the model fibril) as shown in Fig. S13. These were
then subjected to the stretch deformation in an equivalent
manner to the shorter (8  2) fibrils. As expected, the defect
acted as the fracture point in every one of the four repeat
simulations. These simulations indicate that the mechanical
resistance of fibrils depends not only upon peptide sequence
and the relative arrangements of the individual b-strands
within the fibrils, but also upon the number of flaws in the
quasicrystalline peptide array. Consequently, growth condi-
tions that decrease the number of defects—for example, if
amyloid formation takes place very slowly under conditions
that are close to equilibrium—result in fibrils that would be
expected to be more resistant to mechanical stress than those
grown so rapidly that numerous defects are annealed into
their structure.CONCLUSIONS
We have used SMD simulations to probe the mechanical
response of a series of amyloid fibril models built from
peptide sequences chosen to have properties intermediate
between the highly amyloidogenic human amylin fragment
SNNFGAILSS and its nonamyloidogenic rat counterpart.
After equilibration in the absence of an applied force, we
found that the wild-type, the F4L, and I7V variants retained
a high degree of b-sheet content and remained as ordered
fibrillar arrays, and the A6P, F4L-A6P, and F4L-A6P-I7V
variants had increased levels of disorder relative to the
wild-type. We noted that the rIAPP became visibly disor-
dered after 22 ns of MD.
Four distinct deformation protocols that applied force in
different directions were used to induce mechanical failure
in the fibrils, showing that the mechanical response depends
on the direction of the applied force. Consequently, care
must be taken when reporting quantities such as the Young’s
modulus of amyloid fibrils based on experimental measure-
ments or computational data, because the results will differBiophysical Journal 102(3) 587–596depending on the precise manner in which the force is
applied. All aggregates except the disordered rIAPP showed
the greatest mechanical resistance per interface to the
stretch deformation, which directly tests the strength of
the b-sheet hydrogen-bonding interactions parallel to the
long axis of the fibril. The relative strengths of all of the
other interfaces varied with sequence. Whereas stretch pri-
marily interrogates the b-sheet hydrogen-bonding network
common to all fibrils, the resistance to the other deforma-
tions also rely on the molecular details of packing within
the hydrophobic core.
Understanding the impact of the amino-acid sequence on
the mechanical response is also likely to be of therapeutic
importance. In vivo, genetic mutations may lead to the
formation of mechanically less stable fibrils that are prone
to fragmentation. Brittle fibrils would not only potentially
increase the likelihood of early onset of amyloid-related
disease through increased seeding but may also increase
toxicity because the shorter fragments have been shown to
disrupt cell membranes and can have enhanced cytotoxicity
(5,10). Early onset type II diabetes caused by a missense
mutation in the amylin gene within the Japanese population
(49) results in a change of the first serine residue to a
glycine residue in the hIAPP2029 region (SNNFGAILSS
becomes GNNFGAILSS). It has been reported that this
amylin variant shows increased fibrillation kinetics and
enhanced cytotoxicity relative to wild-type amylin (50).
This particular mutation was not explicitly explored in
this study, because changing a terminal residue is unlikely
to influencemechanical behavior as significantly as a nonter-
minal mutation in the full-length protein. Nevertheless, our
simulation results suggest that a plausible mechanism link-
ing enhanced fibrillation to seeding and to cytotoxicity
could be changes in the mechanical properties resulting
from the sequence substitution. Future MD simulations
using the full-length amylin fibrils will now be performed
to test this hypothesis.
The SMD simulations also showed that increased
disorder and the presence of structural defects within the
fibrils consistently reduced their ability to withstand an
applied force by introducing weak points prone to mechan-
ical failure. The observation that defects are able to
dominate mechanical properties is consistent with our
understanding of inorganic materials, such as metals and
ceramics, where the role of dislocations and point and line
defects in structural failure has been extensively studied
(51). It also implies that the mechanical properties of fibrils
will depend on the physical conditions under which they are
formed. Slow nucleation and growth that takes place close
to equilibrium conditions would be expected to result in
fibrils containing fewer defects than those that have grown
rapidly, and would therefore produce fibrils able to resist
higher mechanical stress. It has been suggested that the pref-
erential fracture of fibrils at defect locations can give rise to
a self-healing mechanism that is responsible for the high
MD of Amyloid Fibril Fragmentation 595levels of structural order present in fibrils (19), a hypothesis
that is supported by our MD simulations.
Moreover, a prion strain that has a molecular structure
capable of accommodating numerous defects may well be
inherently more promiscuous than one formed from fibrils
with a unique and high regular quasicrystalline structure,
which would provide another molecular basis, in addition
to seeding, for the observation that frangible prions have
greater infectivity (8). Knowledge of the factors governing
the mechanical performance of amyloid (and amyloidlike)
fibril assemblies will be useful in the design and construc-
tion of nanomaterials (52,53) based on the self-assembly
properties of amyloid for applications such as bioscaffolds,
drug delivery devices (18), and nanowire templates (54). In
such applications, it may even be desirable to engineer
defects into self-assembling systems to produce a material
that is more malleable at the macroscopic level. This could
be achieved, for example, by doping with a low con-
centration of synthetic peptides containing one or more
amino-acid substitutions incapable of forming conventional
hydrogen-bonding interactions within a b-sheet, by mu-
tating the dopant so it includes a disruptive proline residue,
or by introducing a substitution designed to disrupt electro-
static interactions within the mature fibril.
This strategy for nanomaterial design has already been
used in computer simulations of tubular nanostructures
formed from b-helical protein motifs that have shown that
substitutions with synthetic amino acids (such as 1-amino-
cyclopentane-1-carboxylic acid) can alter their structural
stability (55). Steered molecular dynamics simulations,
such as those reported here, could well prove invaluable in
the bottom-up design of novel nanomaterials, as well is in
the design of strategies to decrease fibril fragmentation for
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